Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, November 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 42 articles:
HTML format


 

Single Articles

  1. PEREZ-BEREZO T, Pujo J, Martin P, Le Faouder P, et al
    Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917.
    Nat Commun. 2017;8:1314.
    Abstract    

    Abstract available

  2. JOHNSEN PH, Hilpusch F, Cavanagh JP, Leikanger IS, et al
    Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
    Lancet Gastroenterol Hepatol. 2017 Oct 31. pii: S2468-1253(17)30338.
    Abstract    

    Abstract available

  3. ASANO T, Takenaga M
    Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  4. VICARI E, Salemi M, Sidoti G, Malaguarnera M, et al
    Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  5. ENCK P, Azpiroz F, Boeckxstaens G, Elsenbruch S, et al
    Functional dyspepsia.
    Nat Rev Dis Primers. 2017;3:17081.
    Abstract    

    Abstract available

  6. PATIMAH AW, Lee YY, Dariah MY
    Frequency patterns of core constipation symptoms among the Asian adults: a systematic review.
    BMC Gastroenterol. 2017;17:115.
    Abstract    

    Abstract available

  7. CRAIG O
    New therapies in Irritable Bowel Syndrome: what works and when.
    Curr Opin Gastroenterol. 2017 Nov 1. doi: 10.1097/MOG.0000000000000411.
    Abstract    

    Abstract available

  8. SAMPOGNARO P, Vo KT, Richie M, Blanc PD, et al
    Bismuth Subgallate Toxicity in the Age of Online Supplement Use.
    Neurologist. 2017;22:237-240.
    Abstract    

    Abstract available

  9. TUCK CJ, Vanner SJ
    Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions.
    Neurogastroenterol Motil. 2017 Nov 2. doi: 10.1111/nmo.13238.
    Abstract    

    Abstract available

  10. BARSHOP K, Staller K
    Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy.
    Ther Adv Chronic Dis. 2017;8:153-160.
    Abstract    

    Abstract available

  11. WOHLFARTH C, Schmitteckert S, Hartle JD, Houghton LA, et al
    miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome.
    Sci Rep. 2017;7:14680.
    Abstract    

    Abstract available

  12. SESSENWEIN JL, Baker CC, Pradhananga S, Maitland ME, et al
    Protease-mediated suppression of DRG neuron excitability by commensal bacteria.
    J Neurosci. 2017 Oct 31. pii: 1672-17. doi: 10.1523/JNEUROSCI.1672-17.2017.
    Abstract    

    Abstract available

  13. ZWEIG A, Pohl D

    Praxis (Bern 1994). 2017;106:1229-1235.
    Abstract    



  14. RAHMAN MM, Mahadeva S, Ghoshal UC
    Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.
    World J Gastroenterol. 2017;23:6788-6801.
    Abstract    

    Abstract available

  15. SINAGRA E, Morreale GC, Mohammadian G, Fusco G, et al
    New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.
    World J Gastroenterol. 2017;23:6593-6627.
    Abstract    

    Abstract available

  16. FAN K, Talley NJ
    Functional Dyspepsia and Duodenal Eosinophilia: A New Disease Model.
    J Dig Dis. 2017 Oct 30. doi: 10.1111/1751-2980.12556.
    Abstract    

    Abstract available

  17. RUFFLE JK, Coen SJ, Giampietro V, Williams SCR, et al
    Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans.
    Hum Brain Mapp. 2017 Oct 28. doi: 10.1002/hbm.23850.
    Abstract    

    Abstract available

  18. ZHOU Q, Wesselmann U, Walker L, Lee L, et al
    AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome.
    J Pain. 2017 Oct 24. pii: S1526-5900(17)30737.
    Abstract    

    Abstract available

  19. RIZZO AG, Orlando A, Gallo E, Bisanti A, et al
    Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?
    J Clin Virol. 2017;97:1-3.
    Abstract    

    Abstract available

  20. CAMILLERI M, Ford AC
    Pharmacotherapy for Irritable Bowel Syndrome.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  21. VAN BEURDEN YH, Terveer EM, Keller JJ, Kuijper EJ, et al
    [Faecal microbiota transplantation: indications in perspective].
    Ned Tijdschr Geneeskd. 2017;161:D1623.
    Abstract    

    Abstract available

  22. LACY BE, Patel NK
    Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  23. TAN LH, Li KG, Wu YY, Lan Y, et al
    [Effect of Electroacupuncture at "Yintang" (GV 29) and "Tianshu" (ST 25) on the Ethology and the Expression of TRPV 1 Receptor in Colon of Irritable Bowel Syndrome Rats].
    Zhen Ci Yan Jiu. 2017;42:136-40.
    Abstract    

    Abstract available

  24. SHI H, Zhu X, Cui Y, Qin Y, et al
    Analgesic activity of cynaropicrinon on post-inflammatory irritable bowel syndrome visceral hypersensitivity in a rat model.
    Exp Ther Med. 2017;14:4476-4482.
    Abstract    

    Abstract available

  25. MANDL T, Marsal J, Olsson P, Ohlsson B, et al
    Severe intestinal dysbiosis is prevalent in primary Sjogren's syndrome and is associated with systemic disease activity.
    Arthritis Res Ther. 2017;19:237.
    Abstract    

    Abstract available

  26. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    Abstract    

    Abstract available

  27. IQBAL M, Ezzeldin E, Al-Rashood KA, Al-Shdefat R, et al
    High throughput mu-SPE based elution coupled with UPLC-MS/MS for determination of eluxadoline in plasma sample: Application in pharmacokinetic characterization of PLGA nanoparticle formulations in rats.
    J Pharm Biomed Anal. 2017;149:172-178.
    Abstract    

    Abstract available

  28. WAEHRENS R, Zoller B, Sundquist J, Sundquist K, et al
    A Swedish national adoption study of risk of irritable bowel syndrome (IBS).
    BMJ Open Gastroenterol. 2017;4:e000156.
    Abstract    

    Abstract available

  29. LAATIKAINEN R, Koskenpato J, Hongisto SM, Loponen J, et al
    Pilot Study: Comparison of Sourdough Wheat Bread and Yeast-Fermented Wheat Bread in Individuals with Wheat Sensitivity and Irritable Bowel Syndrome.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  30. ZIA J, Chung CF, Xu K, Dong Y, et al
    Inter-Rater Reliability of Provider Interpretations of Irritable Bowel Syndrome Food and Symptom Journals.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  31. OZAKI RKF, Speridiao PDGL, Soares ACF, Morais MB, et al
    Intestinal fructose malabsorption is associated with increased lactulose fermentation in the intestinal lumen.
    J Pediatr (Rio J). 2017 Oct 28. pii: S0021-7557(17)30001.
    Abstract    

    Abstract available

  32. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
    Eur J Pharmacol. 2017;818:228-234.
    Abstract    

    Abstract available

  33. VORK L, Keszthelyi D, Mujagic Z, Kruimel JW, et al
    Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 Nov 6. doi: 10.1111/nmo.13244.
    Abstract    

    Abstract available

  34. ARENDT-NIELSEN L, Morlion B, Perrot S, Dahan A, et al
    Assessment and manifestation of central sensitisation across different chronic pain conditions.
    Eur J Pain. 2017 Nov 5. doi: 10.1002/ejp.1140.
    Abstract    

    Abstract available

  35. LEI CC, Li L, Zhang H, Li J, et al
    [Effect of Electroacupuncture Stimulation of Sensitized Acupoints on Bowel Dysfunction in Rats with Diarrhea-predominant Irritable Bowel Syndrome].
    Zhen Ci Yan Jiu. 2017;42:413-7.
    Abstract    

    Abstract available

  36. YANG DY, Wang H, Li J, Wu S, et al
    [Effect of Electroacupuncture at "Zusanli" (ST 36) on Vimentin (A Kind of Cytoskeleton Protein Related to Smooth Muscle Contraction) in Rats with Diarrhea-predominant Irritable Bowel Syndrome].
    Zhen Ci Yan Jiu. 2017;42:402-6.
    Abstract    

    Abstract available

  37. SHERWIN LB, Ozoji OM, Boulineaux CM, Joseph PV, et al
    Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  38. SCHUMANN D, Langhorst J, Dobos G, Cramer H, et al
    Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Oct 27. doi: 10.1111/apt.14400.
    Abstract    

    Abstract available

  39. SKODJE GI, Sarna VK, Minelle IH, Rolfsen KL, et al
    Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-reported Non-celiac Gluten Sensitivity.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36302.
    Abstract    

    Abstract available

  40. WAEHRENS R, Li X, Sundquist J, Sundquist K, et al
    Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort.
    Scand J Gastroenterol. 2017 Nov 10:1-8. doi: 10.1080/00365521.2017.1398345.
    Abstract    

    Abstract available

  41. LARSEN T, Hausken T, Otteraaen Ystad S, Hovdenak N, et al
    Does the low FODMAP diet improve symptoms of radiation-induced enteropathy? A pilot study.
    Scand J Gastroenterol. 2017 Nov 7:1-8. doi: 10.1080/00365521.2017.1397186.
    Abstract    

    Abstract available

  42. ZINSMEISTER AR, Herrick LM, Saito Loftus YA, Schleck CD, et al
    Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study.
    Scand J Gastroenterol. 2017 Nov 6:1-10. doi: 10.1080/00365521.2017.1395908.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;